ReviewFrontiers in oncology2025
The potential role of BCL-2 inhibition in amyloidosis and plasma cell leukemia.
Grigorios Alvanidis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewFrontiers in oncology2025
Grigorios Alvanidis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.